Table 2.

Correlation between the expression of LARP4B and the clinic pathologic characteristics in liver cancer.

Clinical characteristics	Variable	No. of patients	LARP4B expression				X 2	P
			High	%	Low	%
Age	<55	117	89	35.32	28	23.33	4.8736	0.0273
	≥55	255	163	64.68	92	76.67
Gender	Female	121	92	36.36	29	24.17	4.9824	0.0256
	Male	252	161	63.64	91	75.83
Histological type	Fibrolamellar carcinoma	3	3	1.19	0	0	4.8737	0.0874
	Hepatocellular carcinoma	363	243	96.05	120	100
	Hepatocholangiocarcinoma (mixed)	7	7	2.77	0	0
Histologic grade	G1	55	27	10.8	28	23.73	18.9592	0.0003
	G2	178	115	46	63	53.39
	G3	123	98	39.2	25	21.19
	G4	12	10	4	2	1.69
Stage	I	172	108	45.96	64	56.14	4.4368	0.218
	II	87	59	25.11	28	24.56
	III	85	64	27.23	21	18.42
	IV	5	4	1.7	1	0.88
T classification	T1	182	117	46.25	65	55.08	6.9572	0.1382
	T2	95	66	26.09	29	24.58
	T3	80	62	24.51	18	15.25
	T4	13	8	3.16	5	4.24
	TX	1	0	0	1	0.85
N classification	N0	253	174	69.05	79	65.83	2.6345	0.2679
	N1	4	4	1.59	0	0
	NX	115	74	29.37	41	34.17
M classification	M0	267	188	74.31	79	65.83	3.2303	0.1989
	M1	4	3	1.19	1	0.83
	MX	102	62	24.51	40	33.33
Radiation therapy	No	340	233	97.08	107	99.07	0.5773	0.4474
	Yes	8	7	2.92	1	0.93
Residual tumor	R0	326	223	88.49	103	90.35	2.9922	0.3928
	R1	17	12	4.76	5	4.39
	R2	1	0	0	1	0.88
	RX	22	17	6.75	5	4.39
Sample type	Primary tumor	371	252	99.6	119	99.17	0	1
	Recurrent tumor	2	1	0.4	1	0.83
Vital status	Deceased	130	98	38.74	32	26.67	4.7032	0.0301
	Living	243	155	61.26	88	73.33